Caplin Point Laboratories Limited (CAPLIPOINT)

2,354.65

INR
-7.85(-0.33%)
As of December 6, 2024 9:59:00 AM

Caplin Point Laboratories Limited Share Price Information

24 hour Low and High

Low: 2303.15
High: 2483.95

All time High

11647.67

Price Change 1h

+₹-7.85 +-0.33%

Price Change 1d

+₹-7.85 +-0.33%

Price Change 1w

+₹403.15 +20.66%

Caplin Point Laboratories Limited Market Information

Exchange

NSE

Market Cap

15097.65 Cr

About Caplin Point Laboratories Limited Share

Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India. The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag formulations, inhalers, and sprays and IV infusion. It also provides dry syrups, lyophilized vials, prefilled syringes, emulsion injection, and topicals. Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

3406

CEO

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Investor Optimism Abounds Caplin Point Laboratories Limited (NSE:CAPLIPOINT) But Growth Is Lacking
  • Federal Bank, Neogen, Caplin Point: 3 stock picks by Axis Securities with up to 19% potential upside
  • Caplin Point Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024
  • After hitting record high in previous session, Caplin Point shares slip over 4%
  • ₹2,142 - That's What Analysts Think Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Is Worth After These Results

FAQs

Caplin Point Laboratories Limited (CAPLIPOINT)

2,354.65

INR
-7.85(-0.33%)
As of December 6, 2024 9:59:00 AM

Caplin Point Laboratories Limited Share Price Information

24 hour Low and High

Low: 2303.15
High: 2483.95

All time High

11647.67

Price Change 1h

+₹-7.85 +-0.33%

Price Change 1d

+₹-7.85 +-0.33%

Price Change 1w

+₹403.15 +20.66%

Caplin Point Laboratories Limited Market Information

Exchange

NSE

Market Cap

15097.65 Cr

About Caplin Point Laboratories Limited Share

Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India. The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag formulations, inhalers, and sprays and IV infusion. It also provides dry syrups, lyophilized vials, prefilled syringes, emulsion injection, and topicals. Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

3406

CEO

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Investor Optimism Abounds Caplin Point Laboratories Limited (NSE:CAPLIPOINT) But Growth Is Lacking
  • Federal Bank, Neogen, Caplin Point: 3 stock picks by Axis Securities with up to 19% potential upside
  • Caplin Point Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024
  • After hitting record high in previous session, Caplin Point shares slip over 4%
  • ₹2,142 - That's What Analysts Think Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Is Worth After These Results

FAQs